anti-WDR5B antibody
CAT.NO. : ARG55016
US$ Please choose
US$ Please choose
Size:
Trail, Bulk size or Custom requests Please contact us
*产品价格可能会有所调整,请以品牌方官网实时更新的价格为准,以确保准确性。
概述
产品描述 | Rabbit Polyclonal antibody recognizes WDR5B |
---|---|
反应物种 | Hu |
应用 | FACS, WB |
宿主 | Rabbit |
克隆 | Polyclonal |
同位型 | IgG |
靶点名称 | WDR5B |
抗原物种 | Human |
抗原 | KLH-conjugated synthetic peptide corresponding to aa. 58-85 (N-terminus) of Human WDR5B. |
偶联标记 | Un-conjugated |
別名 | WD repeat-containing protein 5B |
应用说明
应用建议 |
| ||||||
---|---|---|---|---|---|---|---|
应用说明 | * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. | ||||||
阳性对照 | WiDr |
属性
形式 | Liquid |
---|---|
纯化 | Purification with Protein A and immunogen peptide. |
缓冲液 | PBS and 0.09% (W/V) Sodium azide |
抗菌剂 | 0.09% (W/V) Sodium azide |
存放说明 | For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. |
注意事项 | For laboratory research only, not for drug, diagnostic or other use. |
生物信息
数据库连接 | |
---|---|
基因名称 | WDR5B |
全名 | WD repeat domain 5B |
背景介绍 | This intronless gene encodes a protein containing several WD40 repeats. WD repeats are approximately 30- to 40-amino acid domains containing several conserved residues, including a trp-asp at the C-terminal end. The encoded protein may mediate protein-protein interactions. [provided by RefSeq, Jul 2008] |
生物功能 | May function as a substrate receptor for CUL4-DDB1 ubiquitin E3 ligase complex. [UniProt] |
研究领域 | Gene Regulation antibody |
预测分子量 | 36 kDa |
检测图片 (2)
ARG55016 anti-WDR5B antibody WB image
Western blot: 35 µg of WiDr cell lysate stained with ARG55016 anti-WDR5B antibody.
ARG55016 anti-WDR5B antibody FACS image
Flow Cytometry: WiDr cells stained with ARG55016 anti-WDR5B antibody (right histogram) or without primary antibody control (left histogram), followed by incubation with FITC labelled secondary antibody.
